Baxter Richard B 4
4 · Pelthos Therapeutics Inc. · Filed Jul 7, 2025
Insider Transaction Report
Form 4
Baxter Richard B
Director
Transactions
- Award
Stock Option
2025-07-02+58,230→ 58,230 totalExercise: $13.50From: 2026-07-02Exp: 2035-07-02→ Common Stock (58,230 underlying) - Award
Restricted Stock Units
2025-07-02+19,108→ 19,108 totalExercise: $13.50From: 2026-07-02Exp: 2035-07-02→ Common Stock (19,108 underlying)
Footnotes (2)
- [F1]On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 19,108 shares of common stock at an exercise price of $13.50 per share, which shall vest on a quarterly basis thereafter over a period of three (3) years.
- [F2]On July 2, 2025, the Reporting Person was granted stock options to purchase 58,230 shares of common stock at an exercise price of $13.50 per share, which shall vest on a quarterly basis thereafter over a period of three (3) years.